Einhorn's Greenlight Capital Losses 4% in Q2 as Bubble Basket Proves 'Frustrating'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amazon.com (AMZN) Prime Day Penetration Not as Great as Expected -FBR Capital
July 18, 2017 7:32 AM EDTFBR Capital analyst Susan Anderson offers insight on Amazon.com (NASDAQ: AMZN) Prime Day penetration following surveys to assess purchasing trends and habits of prime customers on July 11th.
Anderson notes surprising data, suggesting only 21% of survery respondents made purchases on Prime... More
Mallinckrodt (MNK) StrataGraft Designated as Regenerative Medicine Advanced Therapy by U.S. FDA
July 18, 2017 7:02 AM EDTMallinckrodt plc (NYSE: MNK), today announced that StrataGraft® regenerative skin tissue is among the first products to be designated as a Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Drug Administration (FDA) under the provisions of the 21st Century Cures Act. The company's investigational, tissue-based therapy is currently under evaluation in a Phase 3 trial to assess its efficacy and safety in the promotion of autologous skin regeneration of complex skin defects due to thermal... More
